Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02742090
Title Evaluate the Efficacy and Safety of TGR-1202 in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors TG Therapeutics, Inc.

chronic lymphocytic leukemia



Age Groups: adult
Covered Countries USA

No variant requirements are available.